These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3073659)

  • 21. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
    Yen CC; Tung SL; Hsieh RK; Chiou TJ; Liu JH; Wang WS; Chen PM
    Jpn J Clin Oncol; 1997 Oct; 27(5):316-20. PubMed ID: 9390208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial.
    Dalla Chiesa M; Tomasello G; Buti S; Rovere RK; Brighenti M; Lazzarelli S; Donati G; Passalacqua R
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):41-8. PubMed ID: 20204366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study.
    Gebbia V; Borsellino N; Testa A; Tirrito M; Varvara F; Cucchiara A; Mauceri G; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(4C):3553-7. PubMed ID: 10629652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil.
    Nozue M; Isaka N; Maruyama T; Kawamoto T; Seino KI; Tanagichi H; Fukao K
    Oncol Rep; 2002; 9(1):93-6. PubMed ID: 11748463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil. A prospective cohort study.
    Moehler M; Gutzler F; Steinmann S; Boehme M; Raeth U; Stremmel W; Galle PR; Rudi J
    Chemotherapy; 2003 May; 49(1-2):85-9. PubMed ID: 12714817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
    Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
    Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
    Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
    Br J Cancer; 2001 Sep; 85(6):798-802. PubMed ID: 11556827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mount Sinai clinical experience with leucovorin and 5-fluorouracil.
    Bruckner HW
    Adv Exp Med Biol; 1988; 244():157-66. PubMed ID: 3073652
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-Fluorouracil and folinic acid: summary of clinical experience.
    Creaven PJ
    Adv Exp Med Biol; 1988; 244():303-11. PubMed ID: 3073664
    [No Abstract]   [Full Text] [Related]  

  • 31. Effective initial therapy of advanced breast cancer with fluorouracil and high-dose, continuous infusion calcium leucovorin.
    Margolin KA; Doroshow JH; Akman SA; Leong LA; Morgan RJ; Raschko JW; Somlo G; Blevins C
    J Clin Oncol; 1992 Aug; 10(8):1278-83. PubMed ID: 1634917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity analysis of the 5-day bolus 5-fluorouracil/folinic acid regimen for the treatment of colorectal carcinoma from 2 randomized controlled trials: a concern about dose.
    Vincent M; Ho C; Tomiak A; Winquist E; Whiston F; Stitt L
    Clin Colorectal Cancer; 2002 Aug; 2(2):111-8. PubMed ID: 12453326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials referral resource. Adjuvant therapy for colon cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Apr; 4(4):67-9, 74, 79-84. PubMed ID: 2143930
    [No Abstract]   [Full Text] [Related]  

  • 34. Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study.
    Van Cutsem E; Filez L; Dewyspelaere J; Penninckx F; Janssens J
    Anticancer Res; 1995; 15(3):1079-80. PubMed ID: 7645929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
    Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.
    Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N
    Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.
    Grem JL; McAtee N; Steinberg SM; Hamilton JM; Murphy RF; Drake J; Chisena T; Balis F; Cysyk R; Arbuck SG
    Cancer Res; 1993 Oct; 53(20):4828-36. PubMed ID: 8402669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study.
    Louvet C; Beerblock K; de Gramont A; Varette C; Demuynck B; Bennamoun M; Cady J; Delfau S; Maisani JE; Krulik M
    Eur J Cancer; 1993; 29A(8):1217. PubMed ID: 8518038
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea.
    Raschko JW; Akman SA; Leong LA; Margolin KA; Morgan RJ; Newman E; Somlo G; Ahn C; Doroshow JH
    Cancer Chemother Pharmacol; 1994; 35(2):161-4. PubMed ID: 7987994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
    Colleoni M; Nelli P; Gaion F; Sgarbossa G; Manente P
    Oncology; 1995; 52(6):435-8. PubMed ID: 7478426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.